OVID
Ovid Therapeutics Inc
2.40$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -408.8% | 56.9% | -3,675.1% | -11,678.8% | -9,886.2% | -528.6% | |
| – | – | – | – | – | – | 2.4% | 0.1% | 91.9% | 407.3% | 108.3% | 3.8% | |
| – | – | – | – | – | – | 59.6% | 2.4% | 436.3% | 1,858.5% | 1,108.8% | 66.3% | |
| – | – | – | – | – | – | 58.1% | 2.4% | 436.3% | – | – | – | |
| – | – | – | – | – | – | 172.9% | -8.1% | -547.8% | 608.6% | -26.5% | -56.6% | |
| – | – | – | – | – | – | 3.1% | 0.1% | 94.4% | 35.1% | 12.5% | 0.0% | |
| – | – | – | – | – | – | 274.6% | -0.9% | -5,848.2% | -658.3% | 9,645.6% | -687.5% | |
| – | – | – | – | – | – | 373.1% | 0.4% | 12.0% | – | – | – | |
| – | – | – | – | – | – | 373.1% | 0.4% | 12.0% | 7,789.6% | 109.9% | 1,037.1% | |
| – | – | – | – | – | – | 238.9% | 56.5% | -9,511.2% | -4,547.5% | -130.7% | -181.3% | |
| – | – | – | – | – | – | -411.9% | 56.8% | -3,769.5% | -11,713.9% | -9,898.8% | -528.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.